These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9552758

  • 21. Current treatment of AL amyloidosis.
    Palladini G, Merlini G.
    Haematologica; 2009 Aug; 94(8):1044-8. PubMed ID: 19644136
    [Abstract] [Full Text] [Related]

  • 22. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, Ikeda S.
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [Abstract] [Full Text] [Related]

  • 23. [Primary amyloidosis associated to severe factor X deficiency].
    Pérez Martínez J, Llamas F, López Montes A, Massó P, Poblet E, López Rubio E, Gallego E, Gómez Roldán C.
    Nefrologia; 2004 Mar; 24(5):493-8. PubMed ID: 15648909
    [Abstract] [Full Text] [Related]

  • 24. Unusual skin manifestation of cutaneous amyloidosis.
    Hung CC, Wang CM, Hong HS, Kuo TT.
    Dermatology; 2003 Mar; 207(1):65-7. PubMed ID: 12835553
    [Abstract] [Full Text] [Related]

  • 25. Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis.
    Sanchorawala V, Wright DG, Seldin DC, Falk RH, Berk JL, Dember LM, Finn KT, Skinner M.
    Br J Haematol; 2002 Jun; 117(4):886-9. PubMed ID: 12060126
    [Abstract] [Full Text] [Related]

  • 26. Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literature.
    Gertz MA, Kyle RA.
    Mayo Clin Proc; 1986 Mar; 61(3):218-23. PubMed ID: 3945122
    [Abstract] [Full Text] [Related]

  • 27. AL amyloidosis: therapeutic response in two patients with renal involvement.
    Goddard IR, Jackson R, Jones JM.
    Nephrol Dial Transplant; 1991 Mar; 6(8):592-4. PubMed ID: 1956560
    [No Abstract] [Full Text] [Related]

  • 28. Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis.
    Tazawa K, Katoh N, Shimojima Y, Matsuda M, Ikeda S.
    Amyloid; 2009 Mar; 16(3):183-5. PubMed ID: 19590992
    [Abstract] [Full Text] [Related]

  • 29. [Effective long-term use of colchicine in secondary AA-amyloidosis].
    Rameev VV, Chegaeva TV, Proskurneva EP.
    Ter Arkh; 1999 Mar; 71(1):54-7. PubMed ID: 10097303
    [No Abstract] [Full Text] [Related]

  • 30. Primary cardiac amyloidosis with 20-year survival.
    Fealey ME, Edwards WD, Grogan M, Dispenzieri A.
    Cardiovasc Pathol; 2006 Mar; 15(6):331-5. PubMed ID: 17113011
    [Abstract] [Full Text] [Related]

  • 31. [Treatment of AL amyloidosis, current data].
    Jaccard A.
    Rev Med Interne; 2006 Nov; 27(11):809-12. PubMed ID: 16934914
    [No Abstract] [Full Text] [Related]

  • 32. [Amyloidosis associated with multiple myeloma].
    Hirota K, Furusawa S.
    Ryoikibetsu Shokogun Shirizu; 1998 Nov; (22 Pt 3):480-3. PubMed ID: 9851195
    [No Abstract] [Full Text] [Related]

  • 33. Unusual cutaneous findings in primary systemic amyloidosis. Report of a case.
    Noojin RO, Arrington TS.
    Arch Dermatol; 1965 Aug; 92(2):157-9. PubMed ID: 11850917
    [Abstract] [Full Text] [Related]

  • 34. [Current management of amyloidosis].
    Hirayama C.
    Nihon Rinsho; 1991 Apr; 49(4):956-60. PubMed ID: 2072560
    [No Abstract] [Full Text] [Related]

  • 35. Amyloidosis.
    Cohen AS, Jones LA.
    Curr Opin Rheumatol; 1991 Feb; 3(1):125-38. PubMed ID: 2043438
    [Abstract] [Full Text] [Related]

  • 36. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
    Ohnishi T, Noguchi S, Murakami N, Tajiri J, Morita M, Tamaru M, Hoshi H, Watanabe K.
    J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo.
    Kyle RA, Greipp PR.
    Blood; 1978 Oct; 52(4):818-27. PubMed ID: 356916
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Nephrotic syndrome secondary to amyloidosis.
    Kneipp S, Himmelstein SB.
    Nurse Pract; 2000 Jun; 25(6 Pt 1):78, 81, 85-6 passim. PubMed ID: 10884998
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.